Li S - Search Results

1

New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer's disease.

Zhang F, Zhong RJ, Cheng C, Li S, Le WD. Zhang F, et al. Among authors: li s. Acta Pharmacol Sin. 2021 Sep;42(9):1382-1389. doi: 10.1038/s41401-020-00565-5. Epub 2020 Dec 2. Acta Pharmacol Sin. 2021. PMID: 33268824 Free PMC article. Review.

2

Free radical scavenging activity and neuroprotective potentials of D138, one Cu(II)/Zn(II) Schiff-base complex derived from N,N'-bis(2-hydroxynaphthylmethylidene)-1,3-propanediamine.

Wang C, Cai ZX, You ZL, Guo HS, Shang DJ, Wang XL, Zhang L, Ma LJ, Tan J, Le WD, Li S. Wang C, et al. Among authors: li s. Neurochem Res. 2014 Sep;39(9):1834-44. doi: 10.1007/s11064-014-1392-1. Epub 2014 Jul 29. Neurochem Res. 2014. PMID: 25069642

3

Pitx3 deficiency produces decreased dopamine signaling and induces motor deficits in Pitx3(-/-) mice.

Le W, Zhang L, Xie W, Li S, Dani JA. Le W, et al. Among authors: li s. Neurobiol Aging. 2015 Dec;36(12):3314-3320. doi: 10.1016/j.neurobiolaging.2015.08.012. Epub 2015 Aug 20. Neurobiol Aging. 2015. PMID: 26363812 Free PMC article.

4

Double-Edged Roles of Nitric Oxide Signaling on APP Processing and Amyloid-β Production In Vitro: Preliminary Evidence from Sodium Nitroprusside.

Cai ZX, Guo HS, Wang C, Wei M, Cheng C, Yang ZF, Chen YW, Le WD, Li S. Cai ZX, et al. Among authors: li s. Neurotox Res. 2016 Jan;29(1):21-34. doi: 10.1007/s12640-015-9564-6. Epub 2015 Oct 1. Neurotox Res. 2016. PMID: 26429731

5

Current Pharmaceutical Treatments and Alternative Therapies of Parkinson's Disease.

Dong J, Cui Y, Li S, Le W. Dong J, et al. Among authors: li s. Curr Neuropharmacol. 2016;14(4):339-55. doi: 10.2174/1570159x14666151120123025. Curr Neuropharmacol. 2016. PMID: 26585523 Free PMC article. Review.

6

Chronic Sleep Deprivation Exacerbates Learning-Memory Disability and Alzheimer's Disease-Like Pathologies in AβPP(swe)/PS1(ΔE9) Mice.

Qiu H, Zhong R, Liu H, Zhang F, Li S, Le W. Qiu H, et al. Among authors: li s. J Alzheimers Dis. 2016;50(3):669-85. doi: 10.3233/JAD-150774. J Alzheimers Dis. 2016. PMID: 26757041

7

Nurr1-Based Therapies for Parkinson's Disease.

Dong J, Li S, Mo JL, Cai HB, Le WD. Dong J, et al. Among authors: li s. CNS Neurosci Ther. 2016 May;22(5):351-9. doi: 10.1111/cns.12536. Epub 2016 Mar 25. CNS Neurosci Ther. 2016. PMID: 27012974 Free PMC article. Review.

8

Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy.

Yang J, Li S, He XB, Cheng C, Le W. Yang J, et al. Among authors: li s. Mol Neurodegener. 2016 May 17;11(1):39. doi: 10.1186/s13024-016-0106-3. Mol Neurodegener. 2016. PMID: 27184028 Free PMC article. Review.

9

Nanomaterial-modulated autophagy: underlying mechanisms and functional consequences.

Zheng W, Wei M, Li S, Le W. Zheng W, et al. Among authors: li s. Nanomedicine (Lond). 2016 Jun;11(11):1417-30. doi: 10.2217/nnm-2016-0040. Epub 2016 May 19. Nanomedicine (Lond). 2016. PMID: 27193191 Review.

10

miR-29 regulates Tet1 expression and contributes to early differentiation of mouse ESCs.

Cui Y, Li T, Yang D, Li S, Le W. Cui Y, et al. Among authors: li s, li t. Oncotarget. 2016 Oct 4;7(40):64932-64941. doi: 10.18632/oncotarget.10751. Oncotarget. 2016. PMID: 27449105 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

99,771 results

Search Page

Filters